APO Research
Talk to an analyst

APO RESEARCH · REPORT

Interleukin 17A

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Interleukin 17A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025188 pages

Choose your research edition.

Industry ResearchInterleukin 17A Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Interleukin 17A Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Interleukin 17A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Interleukin 17A Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Interleukin 17A Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Interleukin 17A market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Interleukin 17A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Interleukin 17A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Interleukin 17A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Interleukin 17A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Interleukin 17A include Abeome Corporation, Affibody AB, Cell Medica Limited, Orega Biotech SAS, AbbVie Inc, Eli Lilly and Company, Merck KGaA, Novartis AG and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Interleukin 17A market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Interleukin 17A and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Interleukin 17A sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Interleukin 17A market size, projected growth trends, production technologies, key applications, and end-use industries.

Interleukin 17A Segment by Company

Abeome Corporation

Affibody AB

Cell Medica Limited

Orega Biotech SAS

AbbVie Inc

Eli Lilly and Company

Merck KGaA

Novartis AG

Johnson & Johnson

Interleukin 17A Segment by Type

DLX-2882

CNTO-6785

ABY-035

Others

Interleukin 17A Segment by Application

Kidney Cancer

Chronic Pain

Liver Cancer

Others

Interleukin 17A Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interleukin 17A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Interleukin 17A and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interleukin 17A.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Interleukin 17A market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Interleukin 17A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Interleukin 17A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Interleukin 17A Industry Trends Table 2. Interleukin 17A Industry Drivers Table 3. Interleukin 17A Industry Opportunities and Challenges Table 4. Interleukin 17A Industry Restraints Table 5. Global Interleukin 17A Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Interleukin 17A Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Interleukin 17A Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Interleukin 17A Sales Market Share by Manufacturers Table 9. Global Interleukin 17A Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Interleukin 17A Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Interleukin 17A Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Interleukin 17A Manufacturers, Product Type & Application Table 13. Global Interleukin 17A Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Interleukin 17A by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DLX-2882 Table 17. Major Manufacturers of CNTO-6785 Table 18. Major Manufacturers of ABY-035 Table 19. Major Manufacturers of Others Table 20. Global Interleukin 17A Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 22. Global Interleukin 17A Sales by Type (2027-2032) & (W Units) Table 23. Global Interleukin 17A Sales Market Share by Type (2021-2026) Table 24. Global Interleukin 17A Sales Market Share by Type (2027-2032) Table 25. Global Interleukin 17A Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Interleukin 17A Revenue by Type (2021-2026) & (W Units) Table 27. Global Interleukin 17A Revenue by Type (2027-2032) & (W Units) Table 28. Global Interleukin 17A Revenue Market Share by Type (2021-2026) Table 29. Global Interleukin 17A Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Kidney Cancer Table 31. Major Manufacturers of Chronic Pain Table 32. Major Manufacturers of Liver Cancer Table 33. Major Manufacturers of Others Table 34. Global Interleukin 17A Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 36. Global Interleukin 17A Sales by Application (2027-2032) & (W Units) Table 37. Global Interleukin 17A Sales Market Share by Application (2021-2026) Table 38. Global Interleukin 17A Sales Market Share by Application (2027-2032) Table 39. Global Interleukin 17A Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 40. Global Interleukin 17A Revenue by Application (2021-2026) & (W Units) Table 41. Global Interleukin 17A Revenue by Application (2027-2032) & (W Units) Table 42. Global Interleukin 17A Revenue Market Share by Application (2021-2026) Table 43. Global Interleukin 17A Revenue Market Share by Application (2027-2032) Table 44. Global Interleukin 17A Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Interleukin 17A Sales by Region (2021-2026) & (W Units) Table 46. Global Interleukin 17A Sales Market Share by Region (2021-2026) Table 47. Global Interleukin 17A Sales Forecasted by Region (2027-2032) & (W Units) Table 48. Global Interleukin 17A Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Interleukin 17A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. North America Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 51. North America Interleukin 17A Sales by Country (2027-2032) & (W Units) Table 52. Europe Interleukin 17A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Europe Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 54. Europe Interleukin 17A Sales by Country (2027-2032) & (W Units) Table 55. Asia Pacific Interleukin 17A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Asia Pacific Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 57. Asia Pacific Interleukin 17A Sales by Country (2027-2032) & (W Units) Table 58. South America, Middle East and Africa Interleukin 17A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. South America, Middle East and Africa Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 60. South America, Middle East and Africa Interleukin 17A Sales by Country (2027-2032) & (W Units) Table 61. Global Interleukin 17A Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Interleukin 17A Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Interleukin 17A Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Interleukin 17A Revenue Market Share by Region (2021-2026) Table 65. Global Interleukin 17A Revenue Market Share by Region (2027-2032) Table 66. Abeome Corporation Company Information Table 67. Abeome Corporation Business Overview Table 68. Abeome Corporation Interleukin 17A Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Abeome Corporation Interleukin 17A Product Portfolio Table 70. Abeome Corporation Recent Development Table 71. Affibody AB Company Information Table 72. Affibody AB Business Overview Table 73. Affibody AB Interleukin 17A Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Affibody AB Interleukin 17A Product Portfolio Table 75. Affibody AB Recent Development Table 76. Cell Medica Limited Company Information Table 77. Cell Medica Limited Business Overview Table 78. Cell Medica Limited Interleukin 17A Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Cell Medica Limited Interleukin 17A Product Portfolio Table 80. Cell Medica Limited Recent Development Table 81. Orega Biotech SAS Company Information Table 82. Orega Biotech SAS Business Overview Table 83. Orega Biotech SAS Interleukin 17A Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Orega Biotech SAS Interleukin 17A Product Portfolio Table 85. Orega Biotech SAS Recent Development Table 86. AbbVie Inc Company Information Table 87. AbbVie Inc Business Overview Table 88. AbbVie Inc Interleukin 17A Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. AbbVie Inc Interleukin 17A Product Portfolio Table 90. AbbVie Inc Recent Development Table 91. Eli Lilly and Company Company Information Table 92. Eli Lilly and Company Business Overview Table 93. Eli Lilly and Company Interleukin 17A Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Eli Lilly and Company Interleukin 17A Product Portfolio Table 95. Eli Lilly and Company Recent Development Table 96. Merck KGaA Company Information Table 97. Merck KGaA Business Overview Table 98. Merck KGaA Interleukin 17A Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Merck KGaA Interleukin 17A Product Portfolio Table 100. Merck KGaA Recent Development Table 101. Novartis AG Company Information Table 102. Novartis AG Business Overview Table 103. Novartis AG Interleukin 17A Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Novartis AG Interleukin 17A Product Portfolio Table 105. Novartis AG Recent Development Table 106. Johnson & Johnson Company Information Table 107. Johnson & Johnson Business Overview Table 108. Johnson & Johnson Interleukin 17A Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Johnson & Johnson Interleukin 17A Product Portfolio Table 110. Johnson & Johnson Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Interleukin 17A Distributors List Table 114. Interleukin 17A Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Interleukin 17A Product Image Figure 2. Global Interleukin 17A Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Interleukin 17A Market Size (2021-2032) & (US$ Million) Figure 4. Global Interleukin 17A Sales (2021-2032) & (W Units) Figure 5. Global Interleukin 17A Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Interleukin 17A Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DLX-2882 Image Figure 9. CNTO-6785 Image Figure 10. ABY-035 Image Figure 11. Others Image Figure 12. Global Interleukin 17A Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Interleukin 17A Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Interleukin 17A Sales Market Share by Type (2021-2032) Figure 15. Global Interleukin 17A Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Interleukin 17A Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Interleukin 17A Revenue Market Share by Type (2021-2032) Figure 18. Kidney Cancer Image Figure 19. Chronic Pain Image Figure 20. Liver Cancer Image Figure 21. Others Image Figure 22. Global Interleukin 17A Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Interleukin 17A Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Interleukin 17A Sales Market Share by Application (2021-2032) Figure 25. Global Interleukin 17A Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Interleukin 17A Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Interleukin 17A Revenue Market Share by Application (2021-2032) Figure 28. North America Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 29. North America Interleukin 17A Sales Market Share by Country (2021-2032) Figure 30. U.S. Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Canada Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Mexico Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Europe Interleukin 17A Sales Market Share by Country (2021-2032) Figure 35. Germany Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 36. France Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 37. U.K. Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Italy Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Netherlands Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Asia Pacific Interleukin 17A Sales Market Share by Country (2021-2032) Figure 42. China Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Japan Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South Korea Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Southeast Asia Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 46. India Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Australia Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South America, Middle East and Africa Interleukin 17A Sales Market Share by Country (2021-2032) Figure 50. Brazil Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South Africa Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Saudi Arabia Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Turkey Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Argentina Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 55. UAE Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Egypt Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Chile Interleukin 17A Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Global Interleukin 17A Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Interleukin 17A Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Interleukin 17A Revenue (2021-2032) & (US$ Million) Figure 61. North America Interleukin 17A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Interleukin 17A Revenue (2021-2032) & (US$ Million) Figure 63. Europe Interleukin 17A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Interleukin 17A Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Interleukin 17A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Interleukin 17A Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Interleukin 17A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Interleukin 17A Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Interleukin 17A Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • DLX-2882
  • CNTO-6785
  • ABY-035
  • Others
Applications
  • Kidney Cancer
  • Chronic Pain
  • Liver Cancer
  • Others
Companies covered
  • Abeome Corporation
  • Affibody AB
  • Cell Medica Limited
  • Orega Biotech SAS
  • AbbVie Inc
  • Eli Lilly and Company
  • Merck KGaA
  • Novartis AG
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Interleukin 17A Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Interleukin 17A Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Interleukin 17A Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Interleukin 17A Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Interleukin 17A Market Dynamics
  1. 2.1 Interleukin 17A Industry Trends
  2. 2.2 Interleukin 17A Industry Drivers
  3. 2.3 Interleukin 17A Industry Opportunities and Challenges
  4. 2.4 Interleukin 17A Industry Restraints
3 Interleukin 17A Market by Manufacturers
  1. 3.1 Global Interleukin 17A Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Interleukin 17A Sales by Manufacturers (2021-2026)
  3. 3.3 Global Interleukin 17A Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Interleukin 17A Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Interleukin 17A Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Interleukin 17A Manufacturers, Product Type & Application
  7. 3.7 Global Interleukin 17A Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Interleukin 17A Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Interleukin 17A Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Interleukin 17A Tier 1, Tier 2, and Tier 3
4 Interleukin 17A Market by Type
  1. 4.1 Interleukin 17A Type Introduction
  2. 4.1.1 DLX-2882
  3. 4.1.2 CNTO-6785
  4. 4.1.3 ABY-035
  5. 4.1.4 Others
  6. 4.2 Global Interleukin 17A Sales by Type
  7. 4.2.1 Global Interleukin 17A Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Interleukin 17A Sales by Type (2021-2032)
  9. 4.2.3 Global Interleukin 17A Sales Market Share by Type (2021-2032)
  10. 4.3 Global Interleukin 17A Revenue by Type
  11. 4.3.1 Global Interleukin 17A Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Interleukin 17A Revenue by Type (2021-2032)
  13. 4.3.3 Global Interleukin 17A Revenue Market Share by Type (2021-2032)
5 Interleukin 17A Market by Application
  1. 5.1 Interleukin 17A Application Introduction
  2. 5.1.1 Kidney Cancer
  3. 5.1.2 Chronic Pain
  4. 5.1.3 Liver Cancer
  5. 5.1.4 Others
  6. 5.2 Global Interleukin 17A Sales by Application
  7. 5.2.1 Global Interleukin 17A Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Interleukin 17A Sales by Application (2021-2032)
  9. 5.2.3 Global Interleukin 17A Sales Market Share by Application (2021-2032)
  10. 5.3 Global Interleukin 17A Revenue by Application
  11. 5.3.1 Global Interleukin 17A Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Interleukin 17A Revenue by Application (2021-2032)
  13. 5.3.3 Global Interleukin 17A Revenue Market Share by Application (2021-2032)
6 Global Interleukin 17A Sales by Region
  1. 6.1 Global Interleukin 17A Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Interleukin 17A Sales by Region (2021-2032)
  3. 6.2.1 Global Interleukin 17A Sales by Region (2021-2026)
  4. 6.2.2 Global Interleukin 17A Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Interleukin 17A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Interleukin 17A Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Interleukin 17A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Interleukin 17A Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Interleukin 17A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Interleukin 17A Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Interleukin 17A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Interleukin 17A Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Interleukin 17A Revenue by Region
  1. 7.1 Global Interleukin 17A Revenue by Region
  2. 7.1.1 Global Interleukin 17A Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Interleukin 17A Revenue by Region (2021-2026)
  4. 7.1.3 Global Interleukin 17A Revenue by Region (2027-2032)
  5. 7.1.4 Global Interleukin 17A Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Interleukin 17A Revenue (2021-2032)
  8. 7.2.2 North America Interleukin 17A Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Interleukin 17A Revenue (2021-2032)
  11. 7.3.2 Europe Interleukin 17A Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Interleukin 17A Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Interleukin 17A Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Interleukin 17A Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Interleukin 17A Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abeome Corporation
  2. 8.1.1 Abeome Corporation Company Information
  3. 8.1.2 Abeome Corporation Business Overview
  4. 8.1.3 Abeome Corporation Interleukin 17A Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abeome Corporation Interleukin 17A Product Portfolio
  6. 8.1.5 Abeome Corporation Recent Developments
  7. 8.2 Affibody AB
  8. 8.2.1 Affibody AB Company Information
  9. 8.2.2 Affibody AB Business Overview
  10. 8.2.3 Affibody AB Interleukin 17A Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Affibody AB Interleukin 17A Product Portfolio
  12. 8.2.5 Affibody AB Recent Developments
  13. 8.3 Cell Medica Limited
  14. 8.3.1 Cell Medica Limited Company Information
  15. 8.3.2 Cell Medica Limited Business Overview
  16. 8.3.3 Cell Medica Limited Interleukin 17A Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cell Medica Limited Interleukin 17A Product Portfolio
  18. 8.3.5 Cell Medica Limited Recent Developments
  19. 8.4 Orega Biotech SAS
  20. 8.4.1 Orega Biotech SAS Company Information
  21. 8.4.2 Orega Biotech SAS Business Overview
  22. 8.4.3 Orega Biotech SAS Interleukin 17A Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Orega Biotech SAS Interleukin 17A Product Portfolio
  24. 8.4.5 Orega Biotech SAS Recent Developments
  25. 8.5 AbbVie Inc
  26. 8.5.1 AbbVie Inc Company Information
  27. 8.5.2 AbbVie Inc Business Overview
  28. 8.5.3 AbbVie Inc Interleukin 17A Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AbbVie Inc Interleukin 17A Product Portfolio
  30. 8.5.5 AbbVie Inc Recent Developments
  31. 8.6 Eli Lilly and Company
  32. 8.6.1 Eli Lilly and Company Company Information
  33. 8.6.2 Eli Lilly and Company Business Overview
  34. 8.6.3 Eli Lilly and Company Interleukin 17A Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly and Company Interleukin 17A Product Portfolio
  36. 8.6.5 Eli Lilly and Company Recent Developments
  37. 8.7 Merck KGaA
  38. 8.7.1 Merck KGaA Company Information
  39. 8.7.2 Merck KGaA Business Overview
  40. 8.7.3 Merck KGaA Interleukin 17A Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck KGaA Interleukin 17A Product Portfolio
  42. 8.7.5 Merck KGaA Recent Developments
  43. 8.8 Novartis AG
  44. 8.8.1 Novartis AG Company Information
  45. 8.8.2 Novartis AG Business Overview
  46. 8.8.3 Novartis AG Interleukin 17A Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis AG Interleukin 17A Product Portfolio
  48. 8.8.5 Novartis AG Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Interleukin 17A Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Interleukin 17A Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Interleukin 17A Value Chain Analysis
  2. 9.1.1 Interleukin 17A Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Interleukin 17A Production Mode & Process
  6. 9.2 Interleukin 17A Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Interleukin 17A Distributors
  9. 9.2.3 Interleukin 17A Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst